Colorectal Cancer Microbiome Research

About BGI

BGI Genomics, founded in 2006 and headquartered in Copenhagen, Denmark, is a global leader in providing integrated genomic sequencing and multi-omics solutions for precision medicine. The company operates a worldwide network of service labs, offering sequencing, mass spectrometry, and data analysis services primarily to the research, clinical, and public health sectors. Its business model is focused on diagnostic services and research partnerships, positioning it as a key infrastructure player in the genomics ecosystem rather than a traditional therapeutic developer. Recent initiatives highlight its work in areas like colorectal cancer microbiome analysis, rare diseases like ALS, and international government partnerships.

Therapeutic Areas

Other Colorectal Cancer Prognosis Drugs